- Franz B & Cie (Haniel) is acquiring a 50.1% stake in Emma – The Sleep Company (Bettzeit). These are the details.
Franz B & Cie (Haniel) is acquiring a 50.1% stake in Emma – The Sleep Company (Bettzeit). Emma’s two founders Manuel Müller und Dr. Dennis Schmoltzi will each have a 24.95% stake in the company and will continue driving Emma’s international expansion as active CEOs.
“With Emma, we are very pleased to have won a young, innovative and at the same time fast-growing company with many unique selling propositions for the further transformation of our portfolio,” said Haniel CEO Thomas Schmidt.
Plus the founders will also have the benefit for the company in the cooperation with Haniel as Co-CEO Dr. Dennis Schmoltzi pointed out:
“With Haniel as an extremely strong partner at our side, we see an excellent opportunity to move to a new level of growth.”
This opportunity also includes the expansion of international business as well as the development of new business areas around the topic of sleeping.
Launched in 2013, Emma – The Sleep Company and developed from an online platform for mattresses and sleeping systems into an internationally operating sleep tech provider that is now one of Europe’s fastest-growing companies.
Now Emma is available in 21 countries worldwide and it has already established itself in many European countries as the leading bed-in-a-box supplier in the constantly growing market for sleep-related products.
Key Quotes:
“Haniel’s clear orientation to create value for generations via a sustainable portfolio is consistent with our strategy of long-term and profitable growth. In combining our diverse research and development competencies, we will take sleep and thus well-being holistically to a new level.”
-Emma founder and co-CEO Manuel Müller
“At present, managing the Corona crisis is part of our everyday life and we care for the well-being of our colleagues and their families. Nevertheless, we remain focused on the implementation of the new Haniel strategy. It creates long-term value and secures jobs. Last year, we decided to invest only in companies that match the topic areas People, Planet or Progress. With Emma as a new company in our group and as the first new building block in our People investment field, we will contribute to a healthy future worth living.”
-Thomas Schmidt
